glutathione and triple negative breast cancer depletion dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative Ratiometrically designed nanoprodrug for triple-negative
Ratiometrically designed nanoprodrug for triple negative breast cancer treatment Mitochondrial Redox Vulnerabilities in Triple Negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic Strategies Role of Glutathione in Cancer: From Mechanisms to Therapies The Potential of Hormonal Therapies for Treatment of Triple Negative Breast Cancer
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



